Transcatheter Arterial Embolization of Abnormal Neovessels for Patellar Tendinopathy: A Safety Evaluation: A Proof-of-Concept Study
- PMID: 40607247
- PMCID: PMC12214352
- DOI: 10.1177/23259671251337093
Transcatheter Arterial Embolization of Abnormal Neovessels for Patellar Tendinopathy: A Safety Evaluation: A Proof-of-Concept Study
Abstract
Background: Patellar tendinopathy (PT) is common among athletes, and the current care is largely palliative.
Purpose: To evaluate the safety of transcatheter arterial embolization (TAE) in patients with PT refractory to nonoperative treatments.
Study design: Case series; Level of evidence, 4.
Methods: This was a multicenter, retrospective study in which recalcitrant PT was treated using TAE. TAE was performed by infusing temporary embolic material through a catheter inserted into the targeted genicular artery. Complications, numeric rating scale (NRS) for pain, Victorian Institute of Sport Assessment for the patella (VISA-P), time to return to training, and ultrasound findings were reported.
Results: Between March 2017 and February 2023, a total of 98 patients with PT underwent TAE. Nine patients were lost to follow-up, and the remaining 89 patients (69 male; mean age, 26.1 ± 11.9 years) were followed up for 1 to 7 years (mean, 31.2 ± 16.1 months) after TAE. No major complications were observed. Mean VISA-P score improved from 24.9 ± 15.3 at baseline to 43.2 ± 21.6, 55.2 ± 22.3, and 67.4 ± 24.7, at 1, 3, and 6 months of follow-up, respectively. Mean NRS for pain improved from 7.6 ± 1.4 at baseline to 4.5 ± 2.3, 3.5 ± 2.4, and 2.7 ± 2.4 at the corresponding time points. VISA-P and NRS scores were 74.6 ± 26.2 and 2.3 ± 2.7, respectively, at the final follow-up. Mean times for return to light and full training were 7.8 ± 8.7 and 14.3 ± 11.5 weeks, respectively. Ultrasound demonstrated decreased patellar tendon thickness (9.5 ± 1.8 mm at baseline vs 6.6 ± 1.3 mm at the final follow-up) without tendon ruptures.
Conclusion: TAE can be considered a safe alternate to existing treatment options for recalcitrant PT. A randomized controlled trial is required to elucidate its efficacy.
Keywords: TAE; jumper’s knee; patellar tendinopathy; transcatheter arterial embolization.
© The Author(s) 2025.
Conflict of interest statement
One or more of the authors has declared the following potential conflict of interest or source of funding: Y.O. has received consulting fees from Asahi Intecc Co, Terumo Corporation, Shimadzu Corporation, and Guerbet and is an advisory board member of Clearfynamic Inc and Nextbiomedical Co. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. Ethical approval for this study was obtained from Medical Corporation Yuyu-kai (OC 2024-014).
Figures





References
-
- Alfredson H, Ohberg L, Forsgren S. Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections. Knee Surg Sports Traumatol Arthrosc. 2003;11(5):334-338. - PubMed
-
- Andriolo L, Altamura SA, Reale D, Candrian C, Zaffagnini S, Filardo G. Nonsurgical treatments of patellar tendinopathy: multiple injections of platelet-rich plasma are a suitable option: a systematic review and meta-analysis. Am J Sports Med. 2019;4(4):1001-1018. - PubMed
-
- Aly M, Fashina C, Hagiga A, Hafez A, Di Mascio L. Transcatheter arterial embolization for the relief of shoulder and elbow chronic joint pain refractory to conventional treatment: systematic review. J Med Imaging Radiat Oncol. 2023;67(7):756-768. - PubMed
-
- Bahr R, Fossan B, Løken S, Engebretsen L. Surgical treatment compared with eccentric training for patellar tendinopathy (jumper’s knee): a randomized, controlled trial. J Bone Joint Surg Am. 2006;88(8):1689-98. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous